Watanabe, H., Ichihara, E., Kayatani, H., Makimoto, G., Ninomiya, K., Nishii, K., . . . Kiura, K. (2021). VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers. Cancer Sci.
Chicago Stili AlıntıWatanabe, Hiromi, et al. "VEGFR2 Blockade Augments the Effects of Tyrosine Kinase Inhibitors By Inhibiting Angiogenesis and Oncogenic Signaling in Oncogene‐driven Non‐small‐cell Lung Cancers." Cancer Sci 2021.
MLA AlıntıWatanabe, Hiromi, et al. "VEGFR2 Blockade Augments the Effects of Tyrosine Kinase Inhibitors By Inhibiting Angiogenesis and Oncogenic Signaling in Oncogene‐driven Non‐small‐cell Lung Cancers." Cancer Sci 2021.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..